富国银行上调渤健目标价至190美元

Core Viewpoint - Wells Fargo raised the target price for Boehringer Ingelheim from $155 to $190 while maintaining a "Hold" rating [1] Group 1 - The target price adjustment reflects a positive outlook on Boehringer Ingelheim's performance [1] - The "Hold" rating indicates a cautious approach towards investment in Boehringer Ingelheim despite the price increase [1]